| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2023 |
SC 13G/A
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT reports a 0% stake in Super Group Limited |
| 02/14/2023 |
SC 13G/A
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT reports a 0.8% stake in Compass, Inc. |
| 02/14/2023 |
SC 13G/A
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT reports a 6.7% stake in Alaunos Therapeutics, Inc. |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
SC 13G/A
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT reports a 6.2% stake in Alaunos Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT reports a 7.7% stake in Super Group Limited |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
SC 13G
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT reports a 6.5% stake in Compass, Inc. |
| 11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/17/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/10/2021 |
SC 13G
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT reports a 5.7% stake in Sports Entertainment Acquisition Corp. |
| 02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/16/2021 |
SC 13G/A
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT reports a 0% stake in Intelsat S.A. |
| 01/07/2021 |
SC 13G
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT reports a 5.1% stake in Ziopharm Oncology Inc |
| 11/16/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/15/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/15/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/14/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/14/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/15/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|